Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06491108
PHASE3

Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

The main objective of this prospective randomized controlled study is to compare safety and efficacy of Vardenafil versus Tadalafil versus Tamsulosin in terms of (voiding function, sexual function and quality of life) in the management of moderate BPH related LUTS.

Official title: Vardenafil Versus Tadalafil Versus Tamsulosin in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Prospective Randomized Study.

Key Details

Gender

MALE

Age Range

40 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2024-06-01

Completion Date

2025-07-01

Last Updated

2024-07-08

Healthy Volunteers

No

Interventions

DRUG

Vardenafil 5 Mg Oral Tablet

Comparing safety and efficacy of Vardenafil 5 mg twice oral daily versus established drugs e.g.Tadalafil 5mg and Tamsulosin 0.4 mg once oral daily in terms of (voiding function, sexual function and quality of life) in the management of moderate BPH related LUTS (benign prostatic hyperplasia related lower urinary tract syptoms )

Locations (1)

Faculity of medicine - Tanta university

Tanta, Gharbia Governorate, Egypt